[STOK] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[STOK] Stoke Therapeutics, Inc.
Announcement Date
14-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -3.70%
YoY- -6.56%
Quarter Report
STOK's Result
STOK's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 3,308 2,905 0 0 0 0 -
PBT -24,542 -26,111 -22,597 -13,684 -8,604 -3,317 49.18%
Tax -3,288 -2,032 -44 -245 -1,362 0 -
NP -24,542 -24,079 -22,597 -13,684 -8,604 -3,317 49.18%
Tax Rate - - - - - - -
Total Cost 27,850 26,984 22,597 13,684 8,604 3,317 53.00%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -741.90 -828.88 0.00 0.00 0.00 0.00 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.55 -0.61 -0.61 -0.41 -0.26 -0.14 31.45%
EPS Diluted -0.55 -0.61 -0.61 -0.41 -0.26 -0.14 31.45%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.